| NCT01024647 | Atlanta Gastroenterology Associates|UCB Pharma | Crohn´s Disease | 2009-12 | PHASE4 |
| NCT00329550 | UCB Japan Co. Ltd. | Crohn´s Disease | 2006-05 | PHASE2 |
| NCT00152425 | UCB Pharma | Crohn´s Disease | 2004-02 | PHASE3 |
| NCT03152058 | David Ware Branch|Hospital for Special Surgery, New York|University of Toronto|NYU Langone Health | High Risk Pregnancy|Pregnancy Complications|Antiphospholipid Syndrome in Pregnancy|Lupus Anticoagulant Disorder | 2017-05-17 | PHASE2 |
| NCT01521923 | UCB Pharma | Rheumatoid Arthritis | 2012-01 | PHASE3 |
| NCT01255761 | UCB Pharma | Rheumatoid Arthritis | 2010-11 | PHASE4 |
| NCT06028438 | Janssen Research & Development, LLC | Arthritis, Rheumatoid | 2023-08-15 | PHASE2 |
| NCT05930613 | Assistance Publique - H?pitaux de Paris | Recurrent Unexplained Implantation Failure | 2023-11-30 | PHASE3 |
| NCT00175877 | UCB Pharma | Rheumatoid Arthritis | 2005-06 | PHASE3 |
| NCT01443364 | UCB Italy s.p.a. | Rheumatoid Arthritis | 2011-12 | PHASE4 |
| NCT03559660 | UCB Biopharma SRL | Crohn´s Disease | | |
| NCT04569890 | RenJi Hospital | Rheumatoid Arthritis|Pregnancy Related | 2020-12-01 | NA |
| NCT00993668 | UCB Pharma | Rheumatoid Arthritis | 2009-09 | PHASE4 |
| NCT00160524 | UCB Pharma SA | Crohn´s Disease | 2004-07 | PHASE3 |
| NCT02293590 | Rüdiger B. Müller|UCB Pharma | Rheumatoid Arthritis | 2013-11 | PHASE2 |
| NCT07491913 | Marmara University | Takayasu Arteritis | 2025-06-15 | NA |
| NCT02597829 | Shafran Gastroenterology Center|UCB Pharma | Crohn´s Disease | 2015-11 | PHASE4 |
| NCT01197066 | Korea Otsuka Pharmaceutical Co., Ltd. | Rheumatoid Arthritis | 2010-03 | PHASE3 |
| NCT00160602 | UCB Pharma | Rheumatoid Arthritis | 2005-06 | PHASE3 |
| NCT02151851 | UCB Pharma SA, Belgium|Parexel | Rheumatoid Arthritis | 2014-07 | PHASE3 |
| NCT00329303 | UCB Pharma | Psoriasis | 2006-04 | PHASE2 |
| NCT00753454 | UCB Pharma | Rheumatoid Arthritis | 2008-09 | PHASE3 |
| NCT03016260 | TcLand Expression S.A.|European Commission | RheumatoId Arthritis | 2016-12 | |
| NCT02365948 | UCB Pharma SA|Parexel | Healthy Subjects | 2015-03 | PHASE1 |
| NCT00717236 | UCB Pharma | Rheumatoid Arthritis | 2008-07 | PHASE3 |
| NCT01374971 | Nathan Wei, MD, FACP, FACR:|University of California, San Diego | Rheumatoid Arthritis | 2011-09 | PHASE3 |
| NCT01500278 | UCB Pharma SA|Parexel | Rheumatoid Arthritis | 2011-12 | PHASE4 |
| NCT04123795 | UCB Biopharma SRL | Moderate Chronic Plaque Psoriasis|Severe Chronic Plaque Psoriasis|Mixed Guttate+Plaque Psoriasis | 2020-01-21 | PHASE3 |
| NCT00160693 | UCB Pharma | Rheumatoid Arthritis | 2003-03 | PHASE3 |
| NCT02505542 | UCB BIOSCIENCES GmbH|Parexel | Axial Spondyloarthrithis|Ankylosing Spondylitis | 2015-07 | PHASE3 |
| NCT03051217 | UCB Biopharma S.P.R.L. | Moderate to Severe Psoriasis|Generalized Pustular Psoriasis and Erythrodermic Psoriasis | 2017-02-21 | PHASE2|PHASE3 |
| NCT03100253 | Mario Negri Institute for Pharmacological Research | Rheumatoid Arthritis | 2018-03-01 | PHASE4 |
| NCT00308581 | UCB Pharma | Crohn´s Disease | 2006-04 | PHASE3 |
| NCT01053559 | Shafran Gastroenterology Center|UCB Pharma | Crohn´s Disease | 2010-01 | NA |
| NCT01519791 | UCB Pharma SA | Rheumatoid Arthritis | 2012-01 | PHASE3 |
| NCT00307931 | UCB Pharma | Crohn´s Disease | 2007-04 | PHASE3 |
| NCT00160641 | UCB Pharma | Rheumatoid Arthritis | 2005-11 | PHASE3 |
| NCT04053881 | UCB Biopharma SRL | Plaque Psoriasis | 2019-08-21 | |
| NCT07352566 | University of California, San Francisco | Psoriasis|Atopic Dermatitis | 2026-01-01 | PHASE4 |
| NCT03293784 | Institut Claudius Regaud | Melanoma | 2017-10-16 | PHASE1 |
| NCT02451748 | University of Illinois at Chicago|UCB Pharma | Rheumatoid Arthritis | 2015-08 | PHASE4 |
| NCT00851318 | Astellas Pharma Inc|UCB Japan Co. Ltd. | Rheumatoid Arthritis | 2009-03 | PHASE3 |
| NCT02132234 | Jagiellonian University|Departmet of Rheumatology, J Dietl Hospital, Krakow, Poland | Rheumatoid Arthritis|Psoriatic Arthritis|Ankylosing Spondylitis|Hypertension | 2013-06 | PHASE4 |
| NCT03215277 | UCB Biopharma SRL | Ankylosing Spondylitis | 2017-10-04 | PHASE2 |
| NCT00245765 | UCB Pharma | Chronic Plaque Psoriasis | 2005-10 | PHASE2 |
| NCT00358683 | UCB Pharma | Crohn´s Disease | 2007-11 | PHASE3 |
| NCT01602302 | Medical University of Graz | Rheumatoid Arthritis | 2012-06 | PHASE4 |
| NCT00291668 | UCB Pharma | Crohn´s Disease | 2006-03-02 | PHASE2 |
| NCT00552058 | UCB Pharma | Crohn Disease | 2008-03 | PHASE3 |
| NCT01235598 | UCB Pharma | Rheumatoid Arthritis | 2010-12 | PHASE3 |
| NCT00333788 | UCB Pharma | Crohn´s Disease | 2006-10 | PHASE3 |
| NCT02346240 | UCB Biopharma S.P.R.L. | Psoriasis|Plaque Psoriasis | 2015-02-11 | PHASE3 |
| NCT00349752 | UCB Pharma | Crohn´s Disease | 2006-11 | PHASE3 |
| NCT00843778 | UCB Pharma | Rheumatoid Arthritis | 2009-01 | PHASE3 |
| NCT03020992 | UCB Biopharma SRL | Axial Spondyloarthritis (axSpA)|Anterior Uveitis (AU) | 2016-12-21 | PHASE4 |
| NCT07138898 | NYU Langone Health | Rheumatic Disease | 2025-09 | PHASE2 |
| NCT03414502 | University of Nebraska | Rheumatoid Arthritis | 2007-12-10 | PHASE3 |
| NCT04725422 | Seattle Children´s Hospital|Boston Children´s Hospital, Boston, MA, USA|Hospital for Special Surgery, New York|Joseph M Sanzari Children´s Hospital, Hackensack University Medical Center, Hackensack, NJ, USA|Riley Children´s Hospital, Indianapolis, IN, USA|University of North Carolina, Chapel Hill, NC, USA|Royal Children´s Hospital|Hacettepe University|Bambino Gesù Children´s Hospital, Rome, Italy|University of British Columbia, Vancouver, BC, Canada|Meyer Children´s Hospital, Florence, Italy|Mansoura University|University of Utah, Salt Lake City, UT, USA|University of Iowa Carver College of Medicine, Iowa City, IA, USA|Ann & Robert H Lurie Children´s Hospital of Chicago|Palacky University Olomouc Institute of Molecular and Translational Medicine, Olomouc, Czechia|Alder Hey Children´s NHS Foundation Trust|University of Calgary | Chronic Nonbacterial Osteomyelitis|Chronic Recurrent Multifocal Osteomyelitis | 2018-08-01 | |
| NCT02326298 | UCB Biopharma S.P.R.L. | Psoriasis|Plaque Psoriasis | 2014-12-16 | PHASE3 |
| NCT01091220 | UCB Pharma | Sperm Quality | 2010-03 | PHASE1 |
| NCT03955861 | Belfast Health and Social Care Trust|British Medical Association|Psoriasis and Psoriatic Arthritis Alliance|Queen´s University, Belfast | Psoriatic Arthritis|Psoriasis|Enthesitis | 2019-02-14 | |
| NCT04740814 | UCB Biopharma SRL | Rheumatoid Arthritis | 2021-02-11 | PHASE1 |
| NCT01292265 | UCB Pharma | Rheumatoid Arthritis | 2011-02 | PHASE3 |
| NCT02326272 | UCB Biopharma S.P.R.L. | Psoriasis|Plaque Psoriasis | 2014-12-15 | PHASE3 |
| NCT00850343 | Astellas Pharma Inc|UCB Japan Co. Ltd. | Rheumatoid Arthritis | 2009-03 | PHASE3 |
| NCT01213017 | Oklahoma Medical Research Foundation|UCB Pharma | Rheumatoid Arthritis | 2010-09 | PHASE3 |
| NCT00297648 | UCB Pharma | Crohn´s Disease | 2006-02 | PHASE3 |
| NCT00813774 | UCB Pharma | Bioavailability Study on Healthy Volunteers | 2008-02 | PHASE1 |
| NCT02497976 | ICStudy, LLC|UCB Pharma | Cystitis, Interstitial | 2015-12-15 | PHASE3 |
| NCT00152386 | UCB Pharma | Rheumatoid Arthritis | 2005-02 | PHASE3 |
| NCT02714881 | Brigham and Women´s Hospital|National Heart, Lung, and Blood Institute (NHLBI) | Rheumatoid Arthritis|Cardiovascular Disease | 2016-10-17 | |
| NCT00152490 | UCB Pharma | Crohn´s Disease | 2003-12 | PHASE3 |
| NCT02073526 | Oslo University Hospital | Inflammatory Bowel Disease|Crohn´s Disease|Ulcerative Colitis | 2013-05 | |
| NCT00580840 | UCB Pharma | Rheumatoid Arthritis | 2007-12 | PHASE4 |
| NCT04991025 | Memorial Sloan Kettering Cancer Center | Lung Cancer|Lung Cancer Stage II|Lung Cancer Stage III | 2022-10-19 | PHASE2 |
| NCT01550003 | UCB BIOSCIENCES GmbH|PRA Health Sciences | Polyarticular-course Juvenile Idiopathic Arthritis (JIA) | 2012-03-08 | PHASE3 |
| NCT02154425 | UCB BIOSCIENCES, Inc.|PPD Development, LP|Parexel | Axial Spondyloarthritis (AxSpA)|Non-radiographic Evidence-AxSpA|Ankylosing Spondylitis|Crohn´s Disease|Psoriatic Arthritis|Rheumatoid Arthritis | 2014-09 | PHASE1 |
| NCT00674362 | UCB Pharma | Rheumatoid Arthritis | 2008-06 | PHASE3 |
| NCT02319642 | UCB Pharma SA|Parexel | Rheumatoid Arthritis | 2014-11 | PHASE3 |
| NCT02019602 | UCB BIOSCIENCES, Inc.|PPD Development, LP|Parexel | Axial Spondyloarthritis (AxSpA)|Non-radiographic Evidence-AxSpA|Ankylosing Spondylitis|Crohn´s Disease|Psoriatic Arthritis|Rheumatoid Arthritis | 2014-01 | PHASE1 |
| NCT02430909 | UCB Celltech|PRA Health Sciences | Rheumatoid Arthritis | 2015-04 | PHASE2 |
| NCT02552212 | UCB BIOSCIENCES GmbH | Axial Spondyloarthritis|Nonradiographic Axial Spondyloarthritis|Nr-axSpA | 2015-09 | PHASE3 |
| NCT00160706 | UCB Pharma SA | Crohn´s Disease | 2004-02 | PHASE3 |
| NCT04610476 | University of Erlangen-Nürnberg Medical School | Psoriatic Arthritis|Withdrawal|Reduction | 2020-10-19 | PHASE3 |
| NCT03559686 | UCB Biopharma SRL | Rheumatoid Arthritis | | |
| NCT00356408 | UCB Pharma | Crohn´s Disease | 2007-01 | PHASE3 |
| NCT04163016 | UCB Biopharma SRL | Rheumatoid Arthritis|Psoriatic Arthritis|Crohn´s Disease|Axial Spondyloarthritis|Plaque Psoriasis | 2020-06-19 | PHASE1 |
| NCT04643483 | UCB Biopharma SRL | Crohn´s Disease | 2021-06 | PHASE3 |
| NCT01864265 | University of Erlangen-Nürnberg Medical School | Rheumatoid Arthritis | 2013-07 | PHASE3 |
| NCT01582568 | Baylor College of Medicine|UCB Pharma | Crohns Disease | 2011-06 | |
| NCT01817972 | Gastroenterology Research of America|UCB Pharma | Crohn´s Disease | 2013-03 | PHASE3 |
| NCT00329420 | UCB Pharma | Crohn´s Disease | 2006-05 | PHASE2 |
| NCT01190410 | UCB Pharma | Crohn´s Disease | 2010-08 | PHASE2 |
| NCT00899678 | UCB Celltech | Crohn´s Disease | 2009-04 | PHASE2 |
| NCT01295151 | Julia Brown | Rheumatoid Arthritis | 2011-08 | PHASE4 |
| NCT01098201 | University of Rochester | Rheumatoid Arthritis | 2010-10 | |
| NCT00791921 | Otsuka Pharmaceutical Co., Ltd.|UCB Japan Co. Ltd. | Rheumatoid Arthritis | 2008-11 | PHASE3 |
| NCT02586246 | Astellas Pharma Inc|UCB Japan Co. Ltd. | Active Rheumatoid Arthritis | 2011-01 | PHASE3 |
| NCT00993317 | Korea Otsuka Pharmaceutical Co., Ltd. | Rheumatoid Arthritis | 2009-10 | PHASE3 |
| NCT00544154 | UCB Pharma | Arthritis, Rheumatoid | 2002-10 | PHASE3 |
| NCT00548834 | UCB Pharma | Rheumatoid Arthritis | 2003-06 | PHASE3 |
| NCT00791999 | Otsuka Pharmaceutical Co., Ltd.|UCB Japan Co. Ltd. | Rheumatoid Arthritis | 2008-11 | PHASE2|PHASE3 |